Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Organic & Biomolecular Chemistry
|
July 21, 2012
Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives
Kate M Clapham, Tommy Rennison, Gavin Jones, et al.
Molecular Cancer Research : MCR
|
July 13, 2016
Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth
Heather Jackson, David Granger, Gavin Jones, et al.
The Journal of Biological Chemistry
|
January 6, 2016
Novel Interaction Mechanism of a Domain Antibody-based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency than Ranibizumab and Bevacizumab and Improved Capacity over Aflibercept
Adam Walker, Chun-Wa Chung, Margarete Neu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 25, 2022
Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases
Shankar Siva, Gavin Jones, Mathias Bressel, et al.
The Lancet. Oncology
|
March 4, 2021
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis
Laila A Gharzai, Ralph Jiang, David Wallington, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Organic & Biomolecular Chemistry
|
July 21, 2012
Potent enantioselective inhibition of DNA-dependent protein kinase (DNA-PK) by atropisomeric chromenone derivatives
Kate M Clapham, Tommy Rennison, Gavin Jones, et al.
Molecular Cancer Research : MCR
|
July 13, 2016
Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth
Heather Jackson, David Granger, Gavin Jones, et al.
The Journal of Biological Chemistry
|
January 6, 2016
Novel Interaction Mechanism of a Domain Antibody-based Inhibitor of Human Vascular Endothelial Growth Factor with Greater Potency than Ranibizumab and Bevacizumab and Improved Capacity over Aflibercept
Adam Walker, Chun-Wa Chung, Margarete Neu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 25, 2022
Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases
Shankar Siva, Gavin Jones, Mathias Bressel, et al.
The Lancet. Oncology
|
March 4, 2021
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis
Laila A Gharzai, Ralph Jiang, David Wallington, et al.
Page
of 3